{"@context":"https:\/\/schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"A Phase 1b\/2 Open-Label Clinical Study to Evaluate the Safety and Efficacy of MK-6070 and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed\/Refractory Extensive-Stage Small Cell Lung Cancer","item":"https:\/\/www.regionalcancercare.org\/trials\/a-phase-1b-2-open-label-clinical-study-to-evaluate-the-safety-and-efficacy-of-mk-6070-and-ifinatamab-deruxtecan-i-dxd-in-participants-with-relapsed-refractory-extensive-stage-small-cell-lung-cancer\/#breadcrumbitem"}]}